tiprankstipranks
Advertisement
Advertisement

CHRO Stock Latest News

Roche announces agreement to acquire PathAI
The FlyRoche announces agreement to acquire PathAI
4d ago
CHRO
FDA blocked publication of studies showing Covid vaccine safe, NYT says
PremiumThe Fly
FDA blocked publication of studies showing Covid vaccine safe, NYT says
6d ago
AZN
BMY
Trump Trade: Microsoft, Google agree to U.S. security reviews of AI models
PremiumThe Fly
Trump Trade: Microsoft, Google agree to U.S. security reviews of AI models
6d ago
AZN
BMY
Lineage Cell announces 36-month results from Phase 1/2a study of RG6501
PremiumThe Fly
Lineage Cell announces 36-month results from Phase 1/2a study of RG6501
7d ago
CHRO
LCTX
Zealand Pharma, Roche to advance petrelintide for weight management to Phase 3
PremiumThe Fly
Zealand Pharma, Roche to advance petrelintide for weight management to Phase 3
12d ago
CHRO
Analyst Reiterates Buy on Roche, Maintains CHF 395 Price Target on Underappreciated Long-Term Pipeline Upside
PremiumRatingsAnalyst Reiterates Buy on Roche, Maintains CHF 395 Price Target on Underappreciated Long-Term Pipeline Upside
14d ago
CHRO
Genentech partners with comedian Damon Wayans for ‘All Eyes on DME’ campaign
Premium
The Fly
Genentech partners with comedian Damon Wayans for ‘All Eyes on DME’ campaign
17d ago
CHRO
Roche upgraded to Equal Weight from Underweight at Morgan Stanley
Premium
The Fly
Roche upgraded to Equal Weight from Underweight at Morgan Stanley
17d ago
CHRO
Roche reports Q1 group sales CHF 14.7B vs. CHF 15.4B last year
PremiumThe Fly
Roche reports Q1 group sales CHF 14.7B vs. CHF 15.4B last year
18d ago
CHRO
Roche expects increase in group sales in mid single digit range for FY26
PremiumThe Fly
Roche expects increase in group sales in mid single digit range for FY26
18d ago
CHRO
Genentech’s treatment of KRAS G12C-positive NSCLC granted FDA orphan designation
PremiumThe Fly
Genentech’s treatment of KRAS G12C-positive NSCLC granted FDA orphan designation
19d ago
CHRO
Genetech says Phase III METEROID study of Enspryng meets primary endpoint
PremiumThe Fly
Genetech says Phase III METEROID study of Enspryng meets primary endpoint
20d ago
CHRO
Roche announces U.S. FDA accepted sBLA for Gazyva/Gazyvaro
PremiumThe FlyRoche announces U.S. FDA accepted sBLA for Gazyva/Gazyvaro
20d ago
CHRO
Roche’s Genentech reports FDA approval of sBLA for Gazyva
Premium
The Fly
Roche’s Genentech reports FDA approval of sBLA for Gazyva
20d ago
CHRO
Trump names Erica Schwartz CDC Director
Premium
The Fly
Trump names Erica Schwartz CDC Director
25d ago
AZN
BMY
Roche decision could hurt Sarepta in U.S., says H.C. Wainwright
PremiumThe Fly
Roche decision could hurt Sarepta in U.S., says H.C. Wainwright
25d ago
CHRO
SRPT
Trump Trade: White House launches space nuclear initiative
PremiumThe Fly
Trump Trade: White House launches space nuclear initiative
25d ago
F
GM
Drugmakers raised prices on hundreds of drugs, NBC News reports
PremiumThe Fly
Drugmakers raised prices on hundreds of drugs, NBC News reports
25d ago
AZN
BMY
C4 Therapeutics expands long-term partnership with Roche
PremiumThe Fly
C4 Therapeutics expands long-term partnership with Roche
1M ago
CCCC
CHRO
Roche price target lowered to $46 from $48 at Morgan Stanley
PremiumThe FlyRoche price target lowered to $46 from $48 at Morgan Stanley
1M ago
CHRO
Compugen initiated with a Buy at Lake Street
Premium
The Fly
Compugen initiated with a Buy at Lake Street
1M ago
AZN
MRK
AbbVie, Genentech to sell popular commercial drugs on TrumpRx, CBS says
Premium
The Fly
AbbVie, Genentech to sell popular commercial drugs on TrumpRx, CBS says
1M ago
ABBV
CHRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >